Acumen Research and Consulting estimate that global Adhesion Barrier Market is expected to reach the market value of around US$ 1.4 Bn by 2027 and is projected to grow at a CAGR of around 7% in terms of revenue amid the forecast period 2020 – 2027.
A barrier to adhesion is used to reduce an irregular skin scar by removing internal tissues and organs after the surgery. Adhesion inhibitors are used for gastrointestinal, orthopedic, reconstructive, neurological and urological procedures and mainly used to heal the coronary artery in cardiovascular surgeries. In comparison with the liquid formulation, the gel and film formulations of adhesion barriers are widely used.
The report provides analysis of global Adhesion Barrier market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2019 is considered as the base year.
Market Insights
Over recent years the number of surgeries carried out globally has significantly grown, with the incidence of chronic illnesses and other health problems. A variety of surgical procedures such as gynecological and abdominal surgeries employ film, gel and liquid adhesion avoidance formulations. These formulations are used at the operating site for the separation of internal tissues and organs and for postoperative adhesion prevention. Therefore, the traumatized tissue surfacing and tissue regeneration strengthen their function as a physical shield. As the number of operations carried out worldwide is increasing, the demand for these products increases.
Around 313 million surgeries are carried out worldwide each year as per The Lancet. The number of chronic diseases such as cardiovascular diseases and arthritis is expected to increase in future years. Growing number traumatic incidents requiring surgical interventions is also driving the adhesion barriers market.
In fact, rising demand for such items grows with the prevalence of sport injuries. The most frequent types of sports injuries reported worldwide are sprains and strains. Stanford Children's Health (SFH) estimates that over 3.5 million US accidents occur in 30 million children who are involved in any competitive sport and one third of all incidents that take place when they are in childhood. The increase in the amount of surgical procedure for sport injury care therefore increases the demand for adhesion protection products, which in turn induces a business rise in the adhesion barrier.
The legal criteria for medical devices membership are dynamic and complicated, mainly due to their related legal aspects. In order for the safety of the population to be guaranteed, quality and the performance of medical devices are required facets. Therefore, the association with medical instruments is met with specific and stringent criteria.
Resorbable adhesion barrier as specified in 21 Code for Regulations (CFR) 812.3(m)(4) is an essential risk apparatus, according to the United States Food and Drug Administration (USFDA). Class III products, which are expected to undergo different certification procedures, such as the USFDA, including investigation application exemptions (IDEs), premarket certification (PMAs), and product development protocol (PDPs), provide a resorbable adhesion barrier. As the regulatory process sometimes takes too many times for medical device approval, these devices are hampered by research and development (R&D). Therefore, the expansion of the accession barrier market to a certain degree restricts specific regulatory criteria.
Regional Stance
Despite of the involvement of leading companies such as Johnson and Johnson, Baxter International, Integra LifeSciences, Anika Therapeutics and FzioMed, North America leads the market. The demand in the Asia Pacific is expected to expand lucratively amid the projected era. The region's strong growth rate is attributable to growing geriatric population and the rising cardiac and neurosurgical surgeries. The area is also projected to be powered by increasing private sector investment in healthcare and by fast-growing medical tourism. High development is anticipated to contribute to the region during the projected period in major countries such as India, China and Japan.
Market Segmentation
Adhesion Barrier Market By Type
Synthetic Adhesion Barriers
Natural Adhesion Barriers
Adhesion Barrier Market By Formulation
Film
Liquid
Gel
Adhesion Barrier Market By Surgeries
General Abdominal
Orthopedic
Gynecological
Cardiovascular
Other
Adhesion Barrier Market By Region
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Adhesion Barrier
1.1. Definition and Scope
1.1.1. Definition of Adhesion Barrier
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Adhesion Barrier Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Adhesion Barrier Market By Type
1.2.3. Adhesion Barrier Market By Formulation
1.2.4. Adhesion Barrier Market By Surgeries
1.2.5. Adhesion Barrier Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Formulation
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio And Market Maturity Analysis of Adhesion Barrier Market
3.5.1. Go To Market Strategy
3.6. Technological Roadmap for Adhesion Barrier Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Adhesion Barrier Market By Type
4.1. Introduction
4.2. Adhesion Barrier Revenue By Type
4.2.1. Adhesion Barrier Revenue (US$ Mn) and Forecast, By Type, 2016-2027
4.2.2. Synthetic Adhesion Barriers
4.2.2.1. Synthetic Adhesion Barriers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Natural Adhesion Barriers
4.2.3.1. Natural Adhesion Barriers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Adhesion Barrier Market Revenue By Formulation
5.1. Introduction
5.2. Adhesion Barrier Revenue (US$ Mn) By Formulation
5.2.1. Adhesion Barrier Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
5.2.2. Film
5.2.2.1. Film Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Liquid
5.2.3.1. Liquid Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Gel
5.2.4.1. Gel Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Adhesion Barrier Market By Surgeries
6.1. Introduction
6.2. Adhesion Barrier Revenue (US$ Mn) By Surgeries
6.2.1. Adhesion Barrier Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
6.2.2. General Abdominal
6.2.2.1. General Abdominal Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Orthopedic
6.2.3.1. Orthopedic Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Gynecological
6.2.4.1. Gynecological Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Cardiovascular
6.2.5.1. Cardiovascular Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Other
6.2.6.1. Other Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Adhesion Barrier Market By Country
7.1. North America Adhesion Barrier Overview
7.2. U.S.
7.2.1. U.S. Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
7.2.2. U.S. Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
7.2.3. U.S. Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
7.3. Canada
7.3.1. Canada Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
7.3.2. Canada Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
7.3.3. Canada Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Adhesion Barrier Market By Country
8.1. Europe Adhesion Barrier Market Overview
8.2. U.K.
8.2.1. U.K. Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.2. U.K. Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.2.3. U.K. Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
8.3. Germany
8.3.1. Germany Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.2. Germany Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.3.3. Germany Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
8.4. France
8.4.1. France Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.4.2. France Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.4.3. France Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
8.5. Spain
8.5.1. Spain Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.5.2. Spain Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.5.3. Spain Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.6.2. Rest of Europe Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016-2027
8.6.3. Rest of Europe Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Adhesion Barrier Market By Country
9.1. Asia Pacific Adhesion Barrier Market Overview
9.2. China
9.2.1. China Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.2.2. China Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
9.2.3. China Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
9.3. Japan
9.3.1. Japan Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.3.2. Japan Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
9.3.3. Japan Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
9.4. India
9.4.1. India Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.4.2. India Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
9.4.3. India Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
9.5. Australia
9.5.1. Australia Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.5.2. Australia Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
9.5.3. Australia Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.6.2. South Korea Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
9.6.3. South Korea Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.7.2. Rest of Asia-Pacific Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
9.7.3. Rest of Asia-Pacific Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Adhesion Barrier Market By Country
10.1. Latin America Adhesion Barrier Market Overview
10.2. Brazil
10.2.1. Brazil Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2. Brazil Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.2.3. Brazil Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2. Mexico Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
10.3.3. Mexico Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2. Rest of Latin America Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 – 2027
10.4.3. Rest of Latin America Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
CHAPTER 11. Middle East & Africa Adhesion Barrier Market By Country
11.1. Middle East & Africa Adhesion Barrier Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2. Saudi Arabia Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
11.2.3. Saudi Arabia Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
11.3. UAE
11.3.1. UAE Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2. UAE Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
11.3.3. UAE Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2. Rest of Middle East & Africa Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Formulation, 2016 - 2027
11.4.3. Rest of Middle East & Africa Adhesion Barrier Market Revenue (US$ Mn) and Forecast By Surgeries, 2016 - 2027
CHAPTER 12. Player Analysis Of Adhesion Barrier
12.1. Adhesion Barrier Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Formulation Launches and Formulation Enhancements
12.2.3. Mergers And Acquisition In Global Adhesion Barrier Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Atrium Medical Corporation
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Atrium Medical Corporation 2019 Adhesion Barrier Business Regional Distribution
13.1.4. Formulation/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Johnson & Johnson
13.3. Medtronic Plc.
13.4. FzioMed, Inc.
13.5. Integra Lifesciences Corporation
13.6. Getinge AB
13.7. Sanofi Group
13.8. Baxter International Inc.
13.9. Anika Therapeutics Inc.
13.10. C. R. Bard, Inc.
13.11. Others
